Related Experiment Video

Updated: Dec 17, 2025

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.6K

The emerging roles of circular RNAs in ovarian cancer

Xuejing Yang1, Jie Mei1, Huiyu Wang1

  • 1Department of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, No. 299 Qingyang Road, Wuxi, 214023 China.

Cancer Cell International
|June 27, 2020
PubMed

Insights

Circular RNAs (circRNAs) are novel regulatory molecules involved in ovarian cancer (OvCa) progression. This review highlights their roles in OvCa development, offering potential diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are unique regulatory noncoding RNA molecules with diverse biological functions.
  • Ovarian cancer (OvCa) is a highly aggressive malignancy often diagnosed at advanced stages.
  • Emerging evidence implicates circRNAs in the pathogenesis and progression of OvCa.

Purpose of the Study:

  • To review the mechanisms by which circRNAs contribute to OvCa progression.
  • To summarize the diagnostic and prognostic potential of circRNAs in OvCa.
  • To explore the therapeutic relevance of circRNAs in managing OvCa.

Main Methods:

  • Literature review of studies on circRNAs and OvCa.
  • Analysis of circRNA functions including gene regulation and miRNA sponging.
  • Evaluation of circRNA expression patterns in OvCa patients.

Main Results:

  • CircRNAs play significant roles in OvCa development and progression through various molecular mechanisms.
  • Specific circRNAs show potential as diagnostic biomarkers for early detection of OvCa.
  • CircRNAs demonstrate prognostic value, correlating with patient outcomes in OvCa.

Conclusions:

  • CircRNAs are crucial players in OvCa pathogenesis.
  • CircRNAs hold promise as valuable biomarkers for OvCa diagnosis and prognosis.
  • Targeting circRNAs may offer novel therapeutic avenues for OvCa treatment.
Keywords:
BiomarkerCircular RNAOvarian cancer

More Related Videos

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.9K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.6K

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K